Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron vs Dexamethasone for IONV in C-Section
NCT05583214Phase 4Unknown
- Start
- Oct 2022
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial in intraoperative nausea and vomiting (IONV) comparing Ondansetron, Dexamethasone and Placebo (3 arms). Primary endpoints: Intraoperative nausea at 20 minutes and Intraoperative vomiting at 1 hour. Status: unknown.
02
Drugs
ondansetrondexamethasone
03
Conditions
intraoperative nausea and vomiting (IONV)
Beyond the preview
Go deeper on NCT05583214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05583214.